This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wienen, W. Articles by Schierok, H.-J. Search for Related Content PubMed PubMed Citation Articles by Wienen, W. Articles by Schierok, H.-J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB HYDROCHLOROTHIAZIDE Social Bookmarking                         What's this?

Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats

Department of Pharmacological Research, Boehringer Ingelheim, Biberach an der Riss, Germany, wolfgang. wienen{at}bc.boehringer-ingelheim.com

Hans-Joachim Schierok

Department of Pharmacological Research, Boehringer Ingelheim, Biberach an der Riss, Germany

The effects of telmisartan and hydrochlorothiazide (HCTZ) alone and in combination on blood pressure (BP) and renal excretory function were investigated in male spontaneously hypertensive rats (SHR) after oral administration for five consecutive days. Four treatments were studied: vehicle (0.5% Natrosol^TM), telmisartan 3 mg/kg, HCTZ 10 mg/kg, and telmisartan 3 mg/kg+ HCTZ 10 mg/kg. The effects on BP and heart rate were studied in 40 SHRs (10 animals per group) using an implanted telemetry device. Renal excretory function was assessed in 76 SHRs (18 animals per group, of which nine were used for urine sampling and nine for blood sampling).

The telmisartan/HCTZ combination produced the greatest reductions in trough DBP (—44±1.5 mmHg), SBP (—60±1.9 mmHg) and mean BP (mBP; —53±1.7 mmHg) after five days of therapy (p<0.05 vs. vehicle and vs. telmisartan). Telmisartan monotherapy also decreased DBP, SBP and mBP significantly (p<0.05), but only minor BP fluctuations occurred in SHRs receiving HCTZ or vehicle. Telmisartan/HCTZ elevated heart rate by approximately 12 beats per minute (p<0.05 vs. control). Significant increases in urine volume and Na⁺, Cl^—, K⁺, creatinine and glucose excretion were observed with HCTZ treatment (p<0.01). Telmisartan/HCTZ also promoted renal water and electrolyte excretion (p<0.01); the diuretic effect appeared to be greater with the combination than with HCTZ alone, and there was some attenuation of urinary K⁺ loss. Elevated blood urea nitrogen levels were observed only in HCTZ-treated SHRs. These results indicate that the antihypertensive efficacy of telmisartan in SHRs is augmented by co-administration with HCTZ. The combination did not affect renal excretory function, with the exception of an increase in blood urea nitrogen and a possible amelioration of HCTZ-related K⁺ depletion.

Key Words: telmisartan • spontaneously hypertensive rat • renal function • blood pressure • AT1-receptor antagonist • potassium • hypertension

Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 2, 123-128 (2001)
DOI: 10.3317/jraas.2001.013


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				X. Zhou, L. C. Matavelli, H. Ono, and E. D. Frohlich Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR Am J Physiol Renal Physiol, October 1, 2005; 289(4): F871 - F879. [Abstract] [Full Text] [PDF]